ClotProtect
London, UK· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
Developing safer next-generation anticoagulants to prevent blood clots with reduced bleeding risk.
CardiovascularHematology
Technology Platform
A discovery platform targeting novel nodes in the coagulation cascade to develop anticoagulants with an improved therapeutic index.
Opportunities
Addressing a multi-billion dollar market with a significant unmet need for safer anti-clotting drugs.
Risk Factors
High clinical and regulatory risk of failing to demonstrate a meaningfully improved safety profile over established therapies.
Competitive Landscape
Competes directly with large pharma's anticoagulant franchises and other biotechs aiming to develop safer successors.